Cancer Research Communications Issues Research Articles in September 2024 Edition
September 09, 2024
September 09, 2024
PHILADELPHIA, Pennsylvania, Sept. 9 -- Cancer Research Communications, a peer-reviewed journal from the American Association for Cancer Research that says it stimulates innovation in cancer science and medicine, published research articles on the following topics in its September 2024 edition (Vol. 4, Issue 9):
* Anti-HDGF Antibody Targets EGFR Tyrosine Kinase Inhibitor-Tolerant Cells in NSCLC Patient-Derived Xenografts
* Inferring Characteristics of the Tumor Immune Mi . . .
* Anti-HDGF Antibody Targets EGFR Tyrosine Kinase Inhibitor-Tolerant Cells in NSCLC Patient-Derived Xenografts
* Inferring Characteristics of the Tumor Immune Mi . . .